Fig. 3: Validation with spike-in experiments with the original primer and probe (n = 3).
From: Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancer
*P < 0.01, **P < 0.001.
Fig. 3: Validation with spike-in experiments with the original primer and probe (n = 3). | BJC Reports
